Deutsche Bank announced on Monday that is was maintaining a “Hold” rating on the New Jersey-based electric utility company NRG Energy Inc. (NRG), but went on to lower its price target for the company.
Greg Poole, an analyst with the firm, commented, “NRG has several diverse businesses – generation, retail, solar, clean energy technologies, and now a separate MLP-like income vehicle for contracted assets. This helps to diversify away from the seemingly perennially challenged merchant generation business, but it also results in an increasingly complex story that may pose a challenge for investors and valuation.” As such, Deutsche Bank announced it was lowering its price target from $27 to $26 a share.
Top 10 Undervalued Stocks To Watch For 2015: First Trust Specialty Finance and Financial Opportunities Fund (FGB)
First Trust Speciality Finance and Financial Opportunities Fund, formerly First Trust/Gallatin Specialty Finance and Financial Opportunities Fund, is a non-diversified, closed-end fund that seeks a high level of current income. The Fund�� secondary objective is to seek total return. The Fund will seek to achieve its investment objectives by investing at least 80% of its managed assets in a portfolio of securities of specialty finance and other financial companies that offer opportunities for income and capital appreciation. The Fund will invest at least 25% of its total assets in securities of companies within industries in the financial sector. First Trust Advisors L.P. (First Trust Advisors) is the Fund's investment adviser.
Specialty finance companies provide capital or financing to businesses and consumers within specified market segments. Specialty finance companies often engage in asset-based and other forms of non-traditional financing activities. The Fund intends to invest primarily in business development company�� (BDC) shares, which are trading in the secondary market on a United States securities exchange but may, in certain circumstances, invest in an initial public offering of BDC shares or invest in certain debt instruments issued by BDCs. The Fund is not limited with respect to the specific types of real estate investment trusts (REITs), in which it invests and intends to invest primarily in REIT shares, which are trading in the secondary market on a United States securities exchange but may, in certain circumstances, invest in an initial public offering of REIT shares or invest in certain debt instruments issued by REITs.
The Fund may invest in commercial mortgage-related securities issued by corporations. These are securities that represent an interest in, or are secured by, mortgage loans secured by commercial property, such as industrial and warehouse properties, office buildings, retail space and shopping malls, multi-family properties and cooperati! ve apartments, hotels and motels, nursing homes, hospitals, and senior living centers. Other mortgage-related securities, in which the Fund may invest include mortgage pass-through securities, collateralized mortgage obligations (CMOs), mortgage dollar rolls, CMO residuals (other than residual interests in real estate mortgage investment conduits), stripped mortgage-backed securities (SMBSs) and other securities that directly or indirectly represent a participation in, or are secured by and payable from, mortgage loans on real property. The Fund may invest in other types of asset-backed securities that are offered in the marketplace. Other asset-backed securities may be collateralized by the fees earned by service providers.
The principal industry groups of financial companies include banks, savings institutions, brokerage firms, investment management companies, insurance companies, holding companies of the foregoing, and companies that provide related services to such companies. Banks and savings institutions provide services to customers such as demand, savings and time deposit accounts and a variety of lending and related services. Brokerage firms provide services to customers in connection with the purchase and sale of securities.
Advisors' Opinion:- [By Shaji Mathew]
JPMorgan also raised the price estimate of First Gulf Bank, (FGB) its top pick among banks in the Middle East and North Africa, to 18 dirhams from 13.50 dirhams. The overweight recommendation was maintained. The stock has risen 25 percent this year to 14.55 dirhams last week.
Best Clean Energy Stocks To Own For 2014: AstraZeneca PLC (AZN)
AstraZeneca PLC (AstraZeneca), incorporated on June 17, 1992, is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. It has a range of medicines that includes treatments for illnesses, such as its antibiotic, Merrem/Meronem and Losec/Prilosec for acid related diseases. AstraZeneca�� products include Crestor, Atacand,Seloken/Toprol-XL, Plendil, Onglyza, Zestril, Symbicort and Zoladex. The Company owns and operates a range of research and development (R&D), production and marketing facilities worldwide. AstraZeneca operates in over 100 countries, including China, Mexico, Brazil and Russia. On August 31, 2011, the Company completed the sale of the Astra Tech business to DENTSPLY International Inc. On June 19, 2012, the Company acquired Ardea Biosciences Inc (Ardea), a biotechnology company in San Diego, California. In July 2012, the Company acquired a portfolio of neuroscience assets from Link Medicine Corporation. In August 2012, Alliance Pharma plc�� wholly owned subsidiary, Alliance Pharmaceuticals Limited, acquired the antimalarial brands Paludrine, Avloclor and Savarine from AstraZeneca UK Limited. In August 2012, the Company and Bristol-Myers Squibb Company announced the acquisition of Amylin Pharmaceuticals, Inc. by Bristol-Myers Squibb Company. In June 2013, the Company acquired Pearl Therapeutics.
Cardiovascular
The Company�� marketed products include Crestor (rosuvastatin calcium), Atacand2 (candesartan cilexetil), Seloken/Toprol-XL (metoprolol succinate), Tenormin (atenolol), Plendil (felodipine), Zestril3 (lisinopril dihydrate), Brilinta/Brilique (ticagrelor), and Axanum, (acetylsalicylic acid (ASA). Crestor1 is a statin used for the treatment of dyslipidaemia and hypercholesterolemia. In some markets, it is also indicated to slow the progression of atherosclerosis and to re! duce the risk of first cardiovascular (CV) events. Atacand2 is an angiotensin II antagonist used for the 1st line treatment of hypertension and symptomatic heart failure. Seloken/Toprol-XL is a beta-blocker once-daily tablet used for 24-hour control of hypertension and for use in heart failure and angina.
Tenormin is a cardioselective beta-blocker used for hypertension, angina pectoris and other CV disorders. Plendil is a calcium antagonist used for the treatment of hypertension and angina. Zestril3 is an angiotensin-converting enzyme inhibitor used for the treatment of a wide range of CV diseases, including hypertension. Brilinta/Brilique is an oral antiplatelet for the treatment of acute coronary syndromes (ACS). Axanum is a fixed dose combination indicated for prevention of CV events in high-risk CV patients in need of daily low-dose ASA treatment and who are at risk of gastric ulcers.
The Company�� marketed products for diabetes include Komboglyze ((saxagliptin and metformin HCl), Kombiglyze XR (saxagliptin and metformin XR) and Onglyza (saxagliptin). Komboglyze is an immediate release fixed dose combination indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients with Type 2 diabetes mellitus inadequately controlled on their maximally tolerated dose of metformin alone or those already being treated with the combination of saxagliptin and metformin as separate tablets. Kombiglyze XR is an extended release fixed dose combination indicated as an adjunct to diet and exercise to improve glycaemic control in adults with Type 2 diabetes mellitus when treatment with both saxagliptin and metformin is appropriate. Onglyza is a DPP-IV inhibitor used for the treatment of Type 2 diabetes.
Gastrointestinal
AstraZeneca�� marketed products include Nexium (esomeprazole), Losec/Prilosec (omeprazole) and Entocort (budesonide). Nexium is a proton pump inhibitor (PPI) used for the treatment of acid-related diseases to offer clini! cal impro! vements over other PPIs and other treatments. Losec/Prilosec is used for the short-term and long-term treatment of acid-related diseases. Entocort is a corticosteroid used for the treatment of inflammatory bowel disease. Nexium is marketed in approximately 120 countries and is available in oral (tablet/capsules and oral suspension) and intravenous (i.v.) dosage forms for the treatment of acid-related diseases.
Infection
The Company�� marketed products include Merrem/Meronem (meropenem), Cubicin (daptomycin) and FluMist/Fluenz (influenza vaccine live, intranasal). Merrem/Meronem is a carbapenem anti-bacterial used for the treatment of serious infections in hospitalised patients. Cubicin is a cyclic lipopeptide anti-bacterial used for the treatment of serious infections in hospitalised patients. FluMist/Fluenz is an intranasal live, attenuated, trivalent influenza vaccine.
Neuroscience
AstraZeneca�� marketed products include Seroquel IR (quetiapine fumarate), Seroquel XR (an extended release formulation of quetiapine fumarate), Zomig (zolmitriptan), Diprivan (propofol), Vimovo (naproxen/esomeprazole magnesium), Naropin (ropivacaine), Xylocaine (lidocaine) and EMLA (lidocaine and prilocaine). Seroquel IR is an atypical anti-psychotic drug used for the treatment of schizophrenia and bipolar disorder (mania, depression and maintenance). Seroquel XR is used for the treatment of schizophrenia, bipolar disorder, MDD and in some territories for generalised anxiety disorder (GAD).
Zomig is used for the treatment of migraines with or without aura and Zomig Nasal Spray is indicated for the acute treatment of cluster. Diprivan is an intravenous general anaesthetic used in the induction and maintenance of general anaesthesia, for use in intensive care sedation and conscious sedation for surgical as well as diagnostic procedures. Vimovo is a fixed-dose combination of enteric-coated naproxen (an NSAID) with the gastroprotection of immediate release ! esomepraz! ole (a proton pump inhibitor) for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and to decrease the developing of gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Naropin is used as a long-acting local anaesthetic, for surgical anaesthesia and acute pain management. Xylocaine is a used short-acting local anaesthetic. EMLA is used as a local anaesthetic for topical application.
Oncology
AstraZeneca�� marketed products include Arimidex (anastrozole), Zoladex (goserelin acetate implant), Casodex (bicalutamide), Iressa (gefitinib), Faslodex (fulvestrant), Nolvadex (tamoxifen citrate) and Caprelsa (vandetanib). Arimidex is an aromatase inhibitor used for the treatment of early breast cancer. Zoladex, in one- and three-month depots, is a luteinising hormone-releasing hormone agonist used for the treatment of prostate cancer, breast cancer and certain benign gynaecological disorders. Casodex is an anti-androgen therapy used for the treatment of prostate cancer.
Advisors' Opinion:- [By John Udovich]
Small cap cancer stock Ariad Pharmaceuticals, Inc (NASDAQ: ARIA) got annihilated yesterday on bad news which seemed to spread like a virus through other biotech stocks, but not all the recent�news surrounding cancer or both large cap and small cap cancer stocks has been�bad as there is good news coming from AstraZeneca plc (NYSE: AZN), Celgene Corporation (NASDAQ: CELG) and MetaStat Inc (OTCMKTS: MTST). Moreover, many investors are distracted by the sideshow going on in Washington DC and may not be paying attention to the following news, good or bad, surrounding the cancer space or cancer stocks:
- [By Lisa Levin]
AstraZeneca PLC (NYSE: AZN) shares climbed 14.97% to $78.94. The volume of AstraZeneca shares traded was 968% higher than normal. AstraZeneca rejected Pfizer's (NYSE: PFE) $76.62 per share bid.
- [By John Udovich]
Different Biotech Strategies Being Pursued in Europe. In the wake of the controverisial Pfizer Inc (NYSE: PFE) pursuit of AstraZeneca plc (NYSE: AZN), FierceBiotech has a detailed article about the different�biotech strategies they along with Johnson & Johnson (NYSE: JNJ)�and Bayer AG (OTCMKTS: BAYRY) are pursuing in Europe. Specifically, AstraZeneca is setting aside 拢5 million ($8.4 million) to fund startups at the Alderley Edge site it is vacating as part of its relocation to Cambridge; Johnson & Johnson has an office in Britain that has inked 16 deals with European biotechs and academic centers last year; and Bayer is inviting biotechs into a new incubator with�three startups housed so far.
- [By Alan Oscroft]
LONDON -- After offering my�pick of our telecom companies�last week, today I'm turning my attention to the FTSE 100 Pharmaceuticals and Biotechnology sector. This time there are three companies that make the top flight --�GlaxoSmithKline� (LSE: GSK ) (NYSE: GSK ) ,�AstraZeneca� (LSE: AZN ) (NYSE: AZN ) and�Shire� (LSE: SHP ) .
Best Clean Energy Stocks To Own For 2014: Safeway Inc.(SWY)
Safeway Inc., together with its subsidiaries, operates as a food and drug retailer in North America. The company operates stores that provide an array of grocery items, food, and general merchandise, as well as features specialty departments, such as bakery, delicatessen, floral, and pharmacy, as well as coffee shops and fuel centers. It also offers SELECT line of products that include baked goods, sparkling ciders and lemonades, salsas, whole bean coffees, frozen pizzas and entrees, and fresh and dry pastas and sauces, as well as an array of ice creams, hors d'oeuvres, and desserts; O ORGANICS line, which comprises milk, chicken, salads, juices, and entrees; Lucerne line of dairy products; Eating Right line of better-for-you products; Bright Green line of home care products; Total Pet Care line of pet foods and pet care products; and Value Red line of value-priced paper goods. As of December 31, 2009, Safeway operated approximately 1,725 stores in California, Oregon, Wash ington, Alaska, Colorado, Arizona, Texas, the Chicago metropolitan area, and the Mid-Atlantic region, as well as British Columbia, Alberta and Manitoba/Saskatchewan. In addition, the company owns and operates GroceryWorks.com Operating Company, LLC, an online grocery channel, doing business under the names Safeway.com, Vons.com, and Genuardis.com; and Blackhawk Network Holdings, Inc., which provides third-party gift cards, prepaid cards, telecom cards, and sports and entertainment cards to North American retailers for sale to retail customers. Additionally, it engages in gift card businesses in the United Kingdom, France, Mexico, and Australia. Further, the company, through a 49% ownership interest in Casa Ley, S.A. de C.V. operates 156 food and general merchandise stores in Western Mexico. The company was formerly known as Safeway Stores, Incorporated and changed its name to Safeway Inc. in February 1990. Safeway was founded in 1915 and is based in Pleasanton, California. Advisors' Opinion:
- [By Steve Symington]
What's more, Whole Foods management plans to increase the total number of domestic stores to 1,000, or nearly triple the 345 total locations it currently maintains. If that sounds aggressive, consider that grocery giant Safeway (NYSE: SWY ) currently has more than 1,600 locations, and the behemoth SUPERVALU� (NYSE: SVU ) boasted more than 5,000 stores at the end of last year.�Compared to both Safeway and SUPERVALU, at least, Whole Foods has plenty of room to grow -- and plenty of market share to grab along the way.
Best Clean Energy Stocks To Own For 2014: Allegiant Travel Co (ALGT)
Allegiant Travel Company, incorporated on April 4, 2006, is a leisure travel company focused on providing travel services and products to residents of small, underserved cities in the United States. The Company operates a passenger airline marketed primarily to leisure travelers in small cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third party services and products. In addition, it provides air transportation under fixed fee flying arrangements. The Company provides scheduled air transportation on limited frequency nonstop flights between small city markets and leisure destinations. As of February 1, 2013, its operating fleet consisted of 58 MD-80 aircraft and six Boeing 757-200 aircraft providing service on 191 routes to 85 cities including 13 leisure destinations and 72 small cities and including cities served seasonally. In January 2012, the Company took ownership of two MD-80 aircraft. In October 2012, the Company announced the formation of Allegiant Systems, a joint venture with AvIntel and Lixar IT.
The Company provides unbundled air-related services and products in conjunction with air transportation for an additional cost to customers. These optional air-related services and products include use of its Website for purchases, use of its call center for purchases, advance seat assignment, baggage fees, priority boarding, its own travel protection product, change fees, food and beverage purchases on board and other air-related services. The Company offers third party travel products, such as hotel rooms, ground transportation (rental cars and hotel shuttle products) and attractions (show tickets) bundled with the purchase of its air transportation.
The Company provides air transportation through fixed fee agreements and charter service on a seasonal and ad-hoc basis for other customers. As of February 1, 2013, its operating aircraft consisted of 58 MD-80 aircraft and six Boeing 757-200 aircraft. D! uring the year ended December 31, 2012, the Company has entered into purchase agreements to acquire seven Airbus A320 aircraft and operating lease agreements for an additional nine Airbus A319 aircraft.
The Company competes with AirTran, Frontier, Spirit, Southwest, US Airways, Alaska Airlines, Horizon Air, Delta, Xtra, United and American.
Advisors' Opinion:- [By Sean Williams]
The comforting fact about many of these charges, if there is one, is that they're usually optional. You don't have to buy a $3 bottle of water from Spirit Airlines (NASDAQ: SAVE ) or pay $17 to $25 for a pillow and blanket from Allegiant Travel (NASDAQ: ALGT ) if you don't want to -- and they're often confined to a single airline. However, one charge is slowly infiltrating the sector that may soon become commonplace and promises to be a game-changer -- namely, the carry-on baggage fee.
- [By Adam Levine-Weinberg]
Allegiant Travel (NASDAQ: ALGT ) has become one of the most successful airlines in the U.S. (albeit not a very well-known one) by attacking a distinct niche: leisure travelers going from small cities to warm weather destinations. Focusing on markets where it does not face any competition has helped Allegiant generate margin performance near the top of the airline industry for the last several years.
Best Clean Energy Stocks To Own For 2014: IAC/InterActiveCorp (IACI)
IAC/InterActiveCorp engages in the Internet business in the United States and internationally. The company�s Search segment develops, markets, and distributes various downloadable toolbars; provides search, reference, and content services through its destination search and other Websites, including Ask.com and Dictionary.com; and aggregates and integrates local advertising and content for distribution to publishers on Web and mobile platforms, as well as markets and distributes mobile applications through which it provides search and additional services. Its Match segment offers subscription-based and advertiser-supported online personals services through its Websites comprising Match.com, Chemistry.com, OurTime.com, BlackPeopleMeet.com, and OkCupid.com, as well as through mobile applications and Meetic-branded Websites. The company�s ServiceMagic segment offers Market Match service that matches consumers with service professionals; Exact Match service, which enables con sumers to review service professional profiles and select the service professional that meets their specific needs; and 1800Contractor.com, an online directory of service professionals. This segment also offers Website design and hosting services. Its Media and Other segment operates CollegeHumor.com, an online entertainment Website that targets young males; Vimeo, a Website on which users can upload, share, and view video; and Pronto.com, a comparison search engine. This segment also engages in the creation of video content for various distribution platforms; and operates as an Internet retailer of footwear and related apparel and accessories, as well as focuses on multimedia business. The company was formerly known as InterActiveCorp and changed its name to IAC/InterActiveCorp in July 2004. IAC/InterActiveCorp was founded in 1986 and is headquartered in New York, New York.
Advisors' Opinion:- [By Timothy Lutts, Publisher, Cabot Heritage Corporation]
In 2004, TripAdvisor (TRIP) was purchased by conglomerate Interactive Corp (IACI), which spun off its travel businesses under the name of Expedia in 2005. In December 2011, TripAdvisor was spun off from Expedia in an IPO.
- [By Monica Gerson]
IAC/InterActiveCorp (NASDAQ: IACI) shares fell 14.51% to $49.50 in the pre-market trading after the company reported downbeat Q3 revenue.
Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets
- [By Lawrence Meyers]
Rather than pick the obvious candidates, I also like to look for great stocks to buy that might not be on most investors��radar. Here are three such stocks to buy:
InterActiveCorp (IACI)InterActiveCorp (IACI) is Barry Diller�� conglomerate of internet companies, not terribly different from John Malone�� Liberty Interactive (LINTA). The strategy for IACI stock has been to wait for a leader in a given sector to emerge and then buy it up, or at least a portion of it. These businesses either have a history of generating lots of cash flow, or have the potential to do so.
- [By Eric Volkman]
Rhyu joins the company from IAC's (NASDAQ: IACI ) Match.com, where he has filled the roles of both CFO and chief administrative officer since 2011. Previous to that, he was a senior vice president at News Corp's (NASDAQ: FOXA ) Dow Jones & Company. He also served as corporate controller for both Sirius XM Radio and GrafTech International (NYSE: GTI ) .
Best Clean Energy Stocks To Own For 2014: Mastercard Incorporated(MA)
MasterCard Incorporated, together with its subsidiaries, provides transaction processing and related services to customers principally in support of their credit, deposit access, electronic cash and automated teller machine payment card programs, and travelers? cheque programs. Its payment solutions include payment programs, marketing, product development, technology, processing, and consulting and information services. The company provides transaction processing services comprising transaction switching, which include authorization, clearing, and settlement; connectivity services, such as network access, equipment, and the transmission of authorization and settlement messages; and other payment-related services consisting of products used to prevent or detect fraudulent transactions, cardholder services, professional consulting and research services, compliance and penalty, account and transaction enhancement services, holograms, and publication services. MasterCard Incor porated manages and licenses payment card brands, including MasterCard, MasterCard Electronic, Maestro, and Cirrus. The company?s payment programs, which are facilitated through its brands, include consumer credit, debit and prepaid programs, commercial payment solutions, and contactless payment solutions. It serves approximately 22,000 financial institutions. The company was founded in 1966 and is headquartered in Purchase, New York.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Getty Images If you've spent any time at all here on DailyFinance, you know that we're actually fans of credit cards -- when they're used correctly. The reasons are legion. Credit cards offer their holders rewards for shopping with them, ranging from airline miles to cash to points redeemable for cash back, account credits, merchandise and gift cards. Credit cards also let you float your debt for as much as a month at a time, before having to pay for your purchases -- rather than having these payments deducted from your account immediately. And as long as that debt is floating, and unpaid, you collect interest on the cash. Just so long as you pay in full every month (and yes, we know that's a big caveat) you get all those benefits at little cost, and build up your credit history and credit score, which can save you an enormous amount of money over a lifetime. But there are other benefits in a credit card that many of us never bother to use -- perhaps because we never know about them. Kiplinger's magazine recently dug up a treasure trove of often-overlooked credit card perks. Here are just three of the biggest: 1. Double the Warranty, Double the Fun When shopping online, it's common to come across products that come with a manufacturer's warranty of 90, 180 or even 365 days. Buy an iPhone 6, for example, and Apple (AAPL) will cover the product for hardware repairs for one full year. Buy a refurbished piece of Apple gear, though, and chances are it'll come with only a 90-day warranty. Meanwhile, an extended-life battery for a competing Samsung (SSNLF) Galaxy SIII can be purchased with 180 days of warranty coverage on Amazon.com (AMZN). But did you know that when paying for these purchases with a credit card, you can often get your warranty period doubled, at no extra charge? As Kiplinger's reveals, all four of the major credit card companies -- Visa (V), MasterCard (MA), American Express (AXP), and even Discover (DFS) -- offer cards that, among their fringe
- [By David Goldman]
Apple is also expected to launch a mobile payments platform that works with the new iPhones and iWatch. Using a technology called "near field communications," or NFC, the new iDevices will be able to interact with payment terminals in a simple tap. Apple reportedly has deals in place with the major credit card companies, including American Express (AXP), MasterCard (MA) and Visa (V).
- [By Mark Morelli]
How will the potential disruption impact business and affect investors? Should the executives at ATM manufacturers such as Diebold (NYSE: DBD ) �be worried? Credit�and debit card processors like MasterCard (NYSE: MA ) and Visa (NYSE: V ) �are already benefiting from the trend to a cashless society. Could things get even better?
- [By Rupert Hargreaves]
Even so, thanks to its checkered past, many companies such as Visa� (NYSE: V ) �and�MasterCard� (NYSE: MA ) �have been late to the party.�However, astute companies, such as�Deutsche Bank� (NYSE: DB ) have been active in the market since the mid 1970s.
No comments:
Post a Comment